EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Flight for fish in drug discovery: a review of zebrafish-based screening of molecules

Surjya Narayan Dash iD, Lipika Patnaik

Biology Letters · 2023-08 · 19 (8)

DOI: 10.1098/rsbl.2022.0541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology Letters, online erschienen am 02.08.2023. Verfasst von Surjya Narayan Dash und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Biocenter 2. Viikinkaari, University of Helsinki, Viikinkaari 5D, 00790 Helsinki, Finland. Hauptthemen laut MEDLINE: Zebrafish, Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human disease and biological practices are modelled in zebrafish ( Danio rerio ) at various phases of drug development as well as toxicity evaluation. The zebrafish is ideal for in vivo pathological research and high-resolution investigation of disease progress. Zebrafish has an advantage over other mammalian models, it is cost-effective, it has external development and embryo transparency, easy to apply genetic manipulations, and open to both forward and reverse genetic techniques. Drug screening in zebrafish is suitable for target identification, illness modelling, high-throughput screening of compounds for inhibition or prevention of disease phenotypes and developing new drugs. Several drugs that have recently entered the clinic or clinical trials have their origins in zebrafish. The sophisticated screening methods used in zebrafish models are expected to play a significant role in advancing drug development programmes. This review highlights the current developments in drug discovery processes, including understanding the action of drugs in the context of disease and screening novel candidates in neurological diseases, cardiovascular diseases, glomerulopathies and cancer. Additionally, it summarizes the current techniques and approaches for the selection of small molecules and current technical limitations on the execution of zebrafish drug screening tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishNeoplasmsAnimalsHumansDrug DiscoveryHigh-Throughput Screening AssaysPhenotypeDisease Models, AnimalMammals

Stichwörter der Autor:innen

disease modeldrug screeningmoleculestoxicityzebrafish

Autor:innen und Institutionen

  • Institute of Biotechnology, Biocenter 2. Viikinkaari, University of Helsinki, Viikinkaari 5D, 00790 Helsinki, Finland.
  • Environmental Science Laboratory, Department of Zoology, COE in Environment and Public Health, Ravenshaw University, Cuttack 751003, Odisha, India.

ORCID-Profile: Surjya Narayan Dash

Zitieren

APA

Dash, S. N., & Patnaik, L. (2023). Flight for fish in drug discovery: a review of zebrafish-based screening of molecules. Biology Letters, 19(8). https://doi.org/10.1098/rsbl.2022.0541

Vancouver

Dash SN, Patnaik L. Flight for fish in drug discovery: a review of zebrafish-based screening of molecules. Biology Letters. 2023;19(8). doi:10.1098/rsbl.2022.0541

BibTeX
@article{Dash2023,
  author = {Dash, Surjya Narayan and Patnaik, Lipika},
  title = {Flight for fish in drug discovery: a review of zebrafish-based screening of molecules},
  journal = {Biology Letters},
  year = {2023},
  volume = {19},
  number = {8},
  doi = {10.1098/rsbl.2022.0541}
}
Kostenlos starten →